{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Princeton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA076477"
        ],
        "brand_name": [
          "ATORVASTATIN CALCIUM"
        ],
        "generic_name": [
          "ATORVASTATIN CALCIUM"
        ],
        "manufacturer_name": [
          "Sun Pharmaceutical Industries Inc."
        ],
        "product_ndc": [
          "63304-827",
          "63304-828",
          "63304-829",
          "63304-830"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ATORVASTATIN CALCIUM TRIHYDRATE"
        ],
        "rxcui": [
          "259255",
          "617310",
          "617311",
          "617312"
        ],
        "spl_id": [
          "24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"
        ],
        "spl_set_id": [
          "595ab888-6b55-4642-a32f-e8521821ed81"
        ],
        "package_ndc": [
          "63304-827-90",
          "63304-827-05",
          "63304-828-90",
          "63304-828-05",
          "63304-829-90",
          "63304-829-05",
          "63304-830-90",
          "63304-830-05"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "48A5M73Z4Q"
        ],
        "upc": [
          "633048279024"
        ]
      },
      "product_type": "Drugs",
      "event_id": "67485",
      "recalling_firm": "Ranbaxy Inc.",
      "address_1": "600 College Rd E Ste 2100",
      "address_2": "",
      "postal_code": "08540-6636",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1086-2014",
      "product_description": "Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90",
      "product_quantity": "64,626 bottles",
      "reason_for_recall": "Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.",
      "recall_initiation_date": "20140116",
      "center_classification_date": "20140221",
      "termination_date": "20150114",
      "report_date": "20140305",
      "code_info": "2407255, 2407256 Exp. 05/14",
      "more_code_info": ""
    }
  ]
}